SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000899140-22-000783
Filing Date
2022-11-09
Accepted
2022-11-09 17:04:45
Documents
1
Group Members
DANIEL S. LOEB

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D (AMENDMENT NO. 1) v110922a.htm SC 13D/A 43652
  Complete submission text file 0000899140-22-000783.txt   45223
Mailing Address 55 HUDSON YARDS NEW YORK NY 10001
Business Address 55 HUDSON YARDS NEW YORK NY 10001 2127153880
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

IRS No.: 133922602 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Subject) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92974 | Film No.: 221373591
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences